Recent
A new study reveals that DMT, a natural psychoactive compound, can significantly reduce stroke-induced brain damage by restoring the blood-brain barrier and curbing inflammation.
October 7, 2025
Source:
Nature
A Psychedelic's Healing Potential
Scientists have uncovered a promising new role for a well-known psychedelic compound in brain recovery following a stroke. A recent study published in Science Advances reveals that DMT (Dimethyltryptamine) can significantly reduce brain damage in both animal and cell models.
The research, conducted by a team from the HUN-REN BRC Institute of Biophysics and Semmelweis University, highlights two key benefits.
Key Discoveries
Barrier Restoration: DMT was found to help repair the blood-brain barrier, a critical defense mechanism for the brain.
Inflammation Control: The compound effectively reduces neuroinflammation, a major cause of secondary damage after a stroke.
These findings suggest DMT could become a vital tool in improving outcomes for stroke survivors.
Keep up with the story. Subscribe to the PR+ free daily newsletter
Source:
http://ScienceDirect.com
How DMT Protects the Brain
The therapeutic effects of DMT appear to stem from a dual-action mechanism that addresses stroke damage on multiple fronts.
Restoring a Critical Shield
A stroke can compromise the blood-brain barrier (BBB), leaving the brain vulnerable. The study found that DMT acts on Sigma-1 receptors to support the astroglial cells responsible for maintaining the BBB's structure and function. This helps restore the protective shield around the brain.
Calming Inflammation
Brain swelling and inflammation are common and dangerous consequences of a stroke. DMT was shown to inhibit the production of proinflammatory cytokines and limit the activation of microglia, the brain's primary immune cells. This targeted anti-inflammatory action helps prevent further neuronal damage.
"DMT acts through Sigma-1 receptors to limit microglial activation and support astroglial cells, creating a dual protective effect," one of the researchers noted.
Read More
Source:
Frontiers
From Lab to Clinical Care
Current treatments for stroke are limited, and many patients do not achieve a full recovery. This reality drives the search for innovative therapies that can be used alongside existing methods.
An Adjuvant Therapy
DMT is not seen as a replacement for current treatments but as a powerful adjuvant therapy. By repairing the BBB and reducing inflammation, it could complement established treatments like thrombolysis and thrombectomy, potentially transforming recovery outcomes for patients.
The Path Forward
The promising results have paved the way for human trials. Researchers are planning to launch Phase 2 clinical trials later in 2025 to evaluate the safety and efficacy of DMT in stroke patients.
Public interest is high, with many questions focusing on the treatment's safety, long-term effects, and eventual accessibility. These trials will be the next critical step in determining if this psychedelic compound can become a mainstream medical treatment for one of the leading causes of disability and death worldwide.
How does DMT specifically restore the blood-brain barrier?
DMT helps restore the blood-brain barrier by acting through Sigma-1 receptors. This mechanism supports astroglial cells, which are essential for maintaining the barrier's integrity and function, thereby protecting the brain from harmful substances that could enter after a stroke.
What are the potential side effects of using DMT for stroke treatment?
How does DMT compare to other potential stroke treatments?
Are there any ethical concerns with using DMT in stroke patients?
What are the next steps for DMT in clinical trials for stroke treatment?
Share this news:
